======= ASCL2 =======
== Gene Information ==
* **Official Symbol**: ASCL2
* **Official Name**: achaete-scute family bHLH transcription factor 2
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=430|430]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q99929|Q99929]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=ASCL2&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ASCL2|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/601886|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: AS-C proteins are involved in the determination of the neuronal precursors in the peripheral nervous system and the central nervous system.
|HLH|
|spongiotrophoblast differentiation|
|negative regulation of Schwann cell proliferation|
|regulation of Schwann cell proliferation|
|spongiotrophoblast layer development|
|negative regulation of glial cell proliferation|
|cell differentiation involved in embryonic placenta development|
|regulation of glial cell proliferation|
|negative regulation of gliogenesis|
|E-box binding|
|somatic stem cell population maintenance|
|RNA polymerase II transcription factor complex|
|embryonic placenta development|
|regulation of gliogenesis|
|stem cell population maintenance|
|maintenance of cell number|
|placenta development|
|protein dimerization activity|
|DNA-binding transcription repressor activity, RNA polymerase II-specific|
|negative regulation of neurogenesis|
|negative regulation of nervous system development|
|RNA polymerase II regulatory region sequence-specific DNA binding|
|transcription factor binding|
|negative regulation of cell development|
|response to hypoxia|
|response to decreased oxygen levels|
|in utero embryonic development|
|response to oxygen levels|
|reproductive structure development|
|reproductive system development|
|embryonic organ development|
|RNA polymerase II proximal promoter sequence-specific DNA binding|
|sensory organ development|
|chordate embryonic development|
|transcription, DNA-templated|
|nucleic acid-templated transcription|
|embryo development ending in birth or egg hatching|
|RNA biosynthetic process|
|developmental process involved in reproduction|
|DNA-binding transcription factor activity|
|negative regulation of cell population proliferation|
|negative regulation of cell differentiation|
|regulation of neurogenesis|
|negative regulation of transcription by RNA polymerase II|
|regulation of nervous system development|
|regulation of cell development|
|negative regulation of developmental process|
|embryo development|
|neuron differentiation|
|nucleobase-containing compound biosynthetic process|
|response to abiotic stimulus|
|heterocycle biosynthetic process|
|aromatic compound biosynthetic process|
|negative regulation of transcription, DNA-templated|
|negative regulation of multicellular organismal process|
|positive regulation of transcription by RNA polymerase II|
|negative regulation of nucleic acid-templated transcription|
|negative regulation of RNA biosynthetic process|
|organic cyclic compound biosynthetic process|
|negative regulation of RNA metabolic process|
|negative regulation of cellular macromolecule biosynthetic process|
|reproductive process|
|reproduction|
|negative regulation of nucleobase-containing compound metabolic process|
|negative regulation of macromolecule biosynthetic process|
|negative regulation of cellular biosynthetic process|
|generation of neurons|
|positive regulation of transcription, DNA-templated|
|negative regulation of biosynthetic process|
|DNA-binding transcription factor activity, RNA polymerase II-specific|
|regulation of cell population proliferation|
|neurogenesis|
|cellular nitrogen compound biosynthetic process|
|positive regulation of nucleic acid-templated transcription|
|positive regulation of RNA biosynthetic process|
|RNA metabolic process|
|cellular macromolecule biosynthetic process|
|negative regulation of gene expression|
|positive regulation of RNA metabolic process|
|tissue development|
|macromolecule biosynthetic process|
|regulation of cell differentiation|
|positive regulation of nucleobase-containing compound metabolic process|
|positive regulation of macromolecule biosynthetic process|
|positive regulation of cellular biosynthetic process|
|positive regulation of gene expression|
|gene expression|
|positive regulation of biosynthetic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp512|Olaparib 4μM R08 exp512]]|1.83|
|[[:results:exp382|Palbociclib 1μM R07 exp382]]|2|
|[[:results:exp355|Dinaciclib 0.007μM R07 exp355]]|2.02|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 8575
* **Expression level (log2 read counts)**: -7.68
{{:chemogenomics:nalm6 dist.png?nolink |}}